Advertisement
For buprenorphine prescribers

Physicians Treating Few Patients With Buprenorphine

0
22 percent of prescribers had monthly census of one to three patients; 9 percent had >75 patients
A non-tumor necrosis factor (TNF)-targeted biologic is more effective than a second anti-TNF drug for treatment of rheumatoid arthritis in patients with insufficient response to a first anti-TNF drug

Non-TNF Biologic Beats Second Anti-TNF in Rheumatoid Arthritis

0
Findings in patients with rheumatoid arthritis with insufficient response to first anti-TNF drug
Stressful events from the day before appear to eradicate any health benefits a person might have gained from choosing a breakfast rich in monounsaturated fats

Stress May Compromise Health Benefits of Eating ‘Good’ Fats

0
However, stress does not seem to make the body's response to 'bad' fats even worse
Antimicrobial resistance remains a major public health threat

NIH: More Must Be Done to Fight Antimicrobial Resistance

0
New government report says multipronged approach is needed
Smoking cigarettes can leave a lasting imprint on human DNA

Smoking Appears to Have Broad, Long-Lasting Impact on DNA

0
Changes related to disease found in more than 7,000 genes, though many 'recover' five years after quitting
Patients with the FTO gene respond to weight-loss strategies as well as those without the gene

FTO Gene Does Not Inhibit Weight Loss Success

0
Lifestyle, environment likely play bigger roles when losing weight, researchers say
Abuse of opioids costs the U.S. economy $78.5 billion a year

Economic Burden of U.S. Opioid Epidemic $78.5 Billion Annually

0
Costs includes health care, lost productivity, treatment programs
The ratio of B-type natriuretic peptide to upper limit of normal for age

BNPratio Predicts Mortality in Degenerative Mitral Regurgitation

0
Predictor of long-term mortality for patients with MR under medical management
Following U.S. Preventive Services Task Force recommendations against routine prostate-specific antigen (PSA) screening

Drop in Use of Digital Rectal Examination, PSA Testing

0
Decreases in use of screening following USPSTF recommendations against routine PSA screening
Gemigliptin combined with metformin is superior to monotherapy with either drug for patients with type 2 diabetes mellitus

Gemigliptin, Metformin Combo Beats Monotherapy in T2DM

0
Greater change in HbA1c from baseline to 24 weeks with combination therapy versus monotherapies